$KALV Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in KalVista Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in KalVista Pharmaceuticals, Inc.. Get notifications about new insider transactions in KalVista Pharmaceuticals, Inc. for free.

Page:   1 2 3 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 28 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseA25.9525,000648,75025,000
May 06 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS24.845,000124,19742,96948 K to 43 K (-10.42 %)
May 06 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...Option ExerciseM10.216,00061,26020,255
May 06 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS24.846,000149,05154,23460.2 K to 54.2 K (-9.96 %)
May 06 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...BuyM10.216,00061,26060,23454.2 K to 60.2 K (+11.06 %)
May 04 2021KALVKalVista Pharmaceu ...Audhya Paul K.Chief Medical Offic ...Option ExerciseA24.97100,0002,497,000100,000
Apr 30 2021KALVKalVista Pharmaceu ...Smith Michael DavidSenior VP, Developm ...Option ExerciseM8.3910,01484,01730,096
Apr 30 2021KALVKalVista Pharmaceu ...Smith Michael DavidSenior VP, Developm ...SellS25.7610,014257,983010 K to 0 (-100.00 %)
Apr 30 2021KALVKalVista Pharmaceu ...Smith Michael DavidSenior VP, Developm ...BuyM8.3910,01484,01710,0140 to 10 K
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseM16.0813,368214,9577,332
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseM8.2114,662120,3756,038
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseM7.9112,856101,6910
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseM7.9136,127285,76512,856
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseM7.9111,01787,14448,983
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.0440,8861,023,589040.9 K to 0 (-100.00 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...BuyM16.0813,368214,95740,88627.5 K to 40.9 K (+48.58 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...BuyM8.2114,662120,37527,51812.9 K to 27.5 K (+114.05 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...BuyM7.9112,856101,69112,8560 to 12.9 K
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.6550713,0050507 to 0 (-100.00 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.5410,000255,38750710.5 K to 507 (-95.17 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.2515,000378,78310,50725.5 K to 10.5 K (-58.81 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.5010,620270,81025,50736.1 K to 25.5 K (-29.40 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...BuyM7.9136,127285,76536,1270 to 36.1 K
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...SellS25.7911,017284,163011 K to 0 (-100.00 %)
Apr 29 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...BuyM7.9111,01787,14411,0170 to 11 K
Mar 19 2021KALVKalVista Pharmaceu ...Stuart NancyDirectorOption ExerciseA34.2714,000479,78014,000
Feb 25 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS31.8750015,93347,96948.5 K to 48 K (-1.03 %)
Feb 25 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS32.943,311109,05948,46951.8 K to 48.5 K (-6.39 %)
Feb 25 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS33.7410,389350,57251,78062.2 K to 51.8 K (-16.71 %)
Feb 25 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS35.3980028,31462,16963 K to 62.2 K (-1.27 %)
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...Option ExerciseM6.7429,642199,78729,611
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...SellS31.771,25639,90865,00066.3 K to 65 K (-1.90 %)
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...SellS33.065,293174,97566,25671.5 K to 66.3 K (-7.40 %)
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...SellS33.7322,093745,27471,54993.6 K to 71.5 K (-23.59 %)
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...SellS35.401,00035,40493,64294.6 K to 93.6 K (-1.06 %)
Feb 25 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...BuyM6.7429,642199,78794,64265 K to 94.6 K (+45.60 %)
Feb 25 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS31.7380025,38454,23455 K to 54.2 K (-1.45 %)
Feb 25 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS32.975,471180,40055,03460.5 K to 55 K (-9.04 %)
Feb 25 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS33.7223,441790,53460,50583.9 K to 60.5 K (-27.92 %)
Feb 25 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS35.191,28845,32583,94685.2 K to 83.9 K (-1.51 %)
Feb 25 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS31.8770722,531169,420170.1 K to 169.4 K (-0.42 %)
Feb 25 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS32.941,57551,877170,127171.7 K to 170.1 K (-0.92 %)
Feb 25 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS33.737,218243,430171,702178.9 K to 171.7 K (-4.03 %)
Feb 25 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS35.4050017,700178,920179.4 K to 178.9 K (-0.28 %)
Feb 08 2021KALVKalVista Pharmaceu ...Smith Michael DavidSenior VP, Developm ...Option ExerciseA10.2016,500168,30016,500
Feb 08 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...Option ExerciseA10.2020,000204,00020,000
Feb 08 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...Option ExerciseA24.2337,500908,62537,500
Feb 08 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...GrantA0.0032,500065,00032.5 K to 65 K (+100.00 %)
Feb 08 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseA10.2010,000102,00010,000
Feb 08 2021KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseA24.2310,000242,30010,000
Feb 08 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...Option ExerciseA10.2020,000204,00020,000
Feb 08 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...Option ExerciseA24.2322,500545,17522,500
Feb 08 2021KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...GrantA0.0012,500085,23472.7 K to 85.2 K (+17.19 %)
Feb 08 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOOption ExerciseA10.2040,000408,00040,000
Feb 08 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOOption ExerciseA24.2375,0001,817,25075,000
Feb 08 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseA10.2020,000204,00020,000
Feb 08 2021KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseA24.2331,000751,13031,000
Jan 06 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOGiftG0.006,0000179,420185.4 K to 179.4 K (-3.24 %)
Jan 06 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS18.8581415,346185,420186.2 K to 185.4 K (-0.44 %)
Jan 06 2021KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS18.139,186166,558186,234195.4 K to 186.2 K (-4.70 %)
Jan 04 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...Option ExerciseM6.743582,41359,253
Jan 04 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...SellS20.043587,17532,50032.9 K to 32.5 K (-1.09 %)
Jan 04 2021KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...BuyM6.743582,41332,85832.5 K to 32.9 K (+1.10 %)
Dec 18 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseA10.2080,000816,00080,000
Dec 18 2020KALVKalVista Pharmaceu ...Smith Michael DavidSenior VP, Developm ...Option ExerciseA10.2025,000255,00025,000
Dec 18 2020KALVKalVista Pharmaceu ...Palleiko Benjamin LCFO, CBO & Secretar ...Option ExerciseA10.2085,000867,00085,000
Dec 18 2020KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseA10.2020,000204,00020,000
Dec 18 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...Option ExerciseA10.2065,000663,00065,000
Dec 18 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOOption ExerciseA10.20140,0001,428,000140,000
Nov 04 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS17.146,000102,81272,73478.7 K to 72.7 K (-7.62 %)
Oct 22 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS19.022,54448,38967,96970.5 K to 68 K (-3.61 %)
Oct 22 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.683,50061,89370,51374 K to 70.5 K (-4.73 %)
Oct 22 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS18.012,30241,46774,01376.3 K to 74 K (-3.02 %)
Oct 22 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.275,64097,41976,31582 K to 76.3 K (-6.88 %)
Oct 22 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS18.755,407101,37478,73484.1 K to 78.7 K (-6.43 %)
Oct 22 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS17.653,60063,55484,14187.7 K to 84.1 K (-4.10 %)
Oct 22 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS18.002,30041,40787,74190 K to 87.7 K (-2.55 %)
Oct 22 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS17.265,60096,68390,04195.6 K to 90 K (-5.86 %)
Oct 22 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS19.013,69370,194195,420199.1 K to 195.4 K (-1.85 %)
Oct 22 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS18.5113,052241,641199,113212.2 K to 199.1 K (-6.15 %)
Oct 22 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.485,800101,412212,165218 K to 212.2 K (-2.66 %)
Oct 22 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS18.014,77685,992217,965222.7 K to 218 K (-2.14 %)
Oct 22 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.2711,218193,786222,741234 K to 222.7 K (-4.79 %)
Oct 20 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.0091415,53981,95582.9 K to 82 K (-1.10 %)
Oct 20 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS17.0099316,88195,64196.6 K to 95.6 K (-1.03 %)
Oct 20 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOGiftG0.003,0000233,959237 K to 234 K (-1.27 %)
Oct 20 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.011,26121,444236,959238.2 K to 237 K (-0.53 %)
Oct 02 2020KALVKalVista Pharmaceu ...Unkart Edward WDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...Edwards MartinDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...SOLAND DANIEL BDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...SOLAND DANIEL BDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...Pereira Brian JGDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...ORONSKY ARNOLD LDirectorOption ExerciseA12.887,00090,1607,000
Oct 02 2020KALVKalVista Pharmaceu ...Cha AlbertDirectorOption ExerciseA12.887,00090,1607,000
Feb 07 2020KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.101001,71082,86983 K to 82.9 K (-0.12 %)
Feb 07 2020KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS17.111001,71196,63496.7 K to 96.6 K (-0.10 %)
Feb 07 2020KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.052003,410238,220238.4 K to 238.2 K (-0.08 %)
Dec 26 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.002,6461187,390
Dec 26 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.022,64645,02582,96985.6 K to 83 K (-3.09 %)
Dec 26 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.002,6461185,61583 K to 85.6 K (+3.19 %)
Dec 26 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.022,30039,150238,420240.7 K to 238.4 K (-0.96 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.003,0101390,036
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.001,500693,046
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.00199194,546
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.053,01051,31882,96986 K to 83 K (-3.50 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.003,0101385,97983 K to 86 K (+3.63 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.051,50025,56882,96984.5 K to 83 K (-1.78 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.001,500684,46983 K to 84.5 K (+1.81 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS17.001993,38382,96983.2 K to 83 K (-0.24 %)
Dec 16 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.00199183,16883 K to 83.2 K (+0.24 %)
Dec 16 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.065,40092,116240,720246.1 K to 240.7 K (-2.19 %)
Dec 16 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.062,20037,536246,120248.3 K to 246.1 K (-0.89 %)
Dec 16 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.001001,700248,320248.4 K to 248.3 K (-0.04 %)
Oct 03 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorOption ExerciseA11.217,00078,4707,000
Oct 03 2019KALVKalVista Pharmaceu ...ORONSKY ARNOLD LDirectorOption ExerciseA11.217,00078,4707,000
Oct 03 2019KALVKalVista Pharmaceu ...Unkart Edward WDirectorOption ExerciseA11.217,00078,4707,000
Sep 30 2019KALVKalVista Pharmaceu ...SOLAND DANIEL BDirectorBuyP11.877,96294,49810,0002 K to 10 K (+390.68 %)
Sep 30 2019KALVKalVista Pharmaceu ...SOLAND DANIEL BDirectorBuyP11.902,03824,2522,0380 to 2 K
Jul 30 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP17.135,13788,011124,566119.4 K to 124.6 K (+4.30 %)
Jul 30 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP17.1324,730423,6921,022,493997.8 K to 1 M (+2.48 %)
Jul 30 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP16.8321,942369,317997,763975.8 K to 997.8 K (+2.25 %)
Jul 30 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP16.834,55876,718119,429114.9 K to 119.4 K (+3.97 %)
Jul 24 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.007,3553294,745
Jul 24 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS18.357,355134,93082,96990.3 K to 83 K (-8.14 %)
Jul 24 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.007,3553290,32483 K to 90.3 K (+8.86 %)
Jul 24 2019KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS18.651,90035,43996,73498.6 K to 96.7 K (-1.93 %)
Jul 24 2019KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...SellS18.571,40026,00498,634100 K to 98.6 K (-1.40 %)
Jul 19 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP17.8449,680886,127975,821926.1 K to 975.8 K (+5.36 %)
Jul 19 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP17.6810,320182,453114,871104.6 K to 114.9 K (+9.87 %)
Jul 19 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP16.932203,724104,551104.3 K to 104.6 K (+0.21 %)
Jul 19 2019KALVKalVista Pharmaceu ...Cha AlbertDirectorBuyP16.971,06017,991926,141925.1 K to 926.1 K (+0.11 %)
Jul 17 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS17.0410,000170,407248,510258.5 K to 248.5 K (-3.87 %)
Jun 28 2019KALVKalVista Pharmaceu ...Edwards MartinDirectorOption ExerciseA20.6214,000288,68014,000
May 17 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...Option ExerciseA24.2333,750817,76333,750
May 17 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseA24.2327,900676,01727,900
May 17 2019KALVKalVista Pharmaceu ...Maetzel AndreasSenior Vice Preside ...Option ExerciseA24.239,000218,0709,000
May 17 2019KALVKalVista Pharmaceu ...Feener Edward P.Chief Scientific Of ...Option ExerciseA24.2320,250490,65820,250
May 17 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOOption ExerciseA24.2367,5001,635,52567,500
Apr 23 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...Option ExerciseM0.007,35532102,100
Apr 23 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS26.791,00026,78682,96984 K to 83 K (-1.19 %)
Apr 23 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...SellS25.926,355164,74483,96990.3 K to 84 K (-7.04 %)
Apr 23 2019KALVKalVista Pharmaceu ...Yea ChristopherChief Development O ...BuyM0.007,3553290,32483 K to 90.3 K (+8.86 %)
Apr 23 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS25.923007,777258,510258.8 K to 258.5 K (-0.12 %)
Apr 23 2019KALVKalVista Pharmaceu ...Crockett Thomas AndrewCEOSellS24.769,700240,181258,810268.5 K to 258.8 K (-3.61 %)
Apr 23 2019KALVKalVista Pharmaceu ...SOLAND DANIEL BDirectorOption ExerciseA26.4014,000369,60014,000
Apr 22 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...Option ExerciseM8.392,00016,78047,354
Apr 22 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...Option ExerciseM6.741,0737,23259,611
Apr 22 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...SellS25.802,00051,60332,50034.5 K to 32.5 K (-5.80 %)
Apr 22 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...BuyM8.392,00016,78034,50032.5 K to 34.5 K (+6.15 %)
Apr 22 2019KALVKalVista Pharmaceu ...Palleiko Benjamin LCBO, CFO and Secret ...SellS25.511,07327,37332,50033.6 K to 32.5 K (-3.20 %)

Page:   1 2 3 next >

Contact us | Follow us on Twitter